Fetal MRI - CAM 729

GENERAL INFORMATION
It is an expectation that all patients receive care/services from a licensed clinician. All appropriate supporting documentation, including recent pertinent office visit notes, laboratory data, and results of any special testing must be provided. If applicable: All prior relevant imaging results and the reason that alternative imaging cannot be performed must be included in the documentation submitted.

Where a specific clinical indication is not directly addressed in this guideline, medical necessity determination will be made based on widely accepted standard of care criteria. These criteria are supported by evidence-based or peer-reviewed sources such as medical literature, societal guidelines and state/national recommendations.

Policy 
(For evaluating the placenta or imaging the maternal pelvis without need for fetal assessment, use the pelvic MRI guideline, CAM 714)

INDICATIONS FETAL MRI
To better define or confirm any of the following:

  • Known or suspected abnormality of the fetus after ultrasound has been performed1
  • Fetal surgery is planned
  • Make a decision about therapy, delivery, or to advise the family about prognosis1

Combination Studies
Pelvis and Fetal MRI

  • When medical necessity has been met for Pelvis MRI (such as for suspected placenta accreta or percreta when ultrasound is indeterminate2) AND medical necessity has been met for Fetal MRI (such as suspected fetal abnormality after ultrasound has been performed), two separate authorizations are required: Pelvis MRI Pelvis MRI (CPT 72195, 72196, 72197) and Fetal MRI (CPT 74712, +74713).

Purpose
Fetal MRI1

Fetal MRI should be performed only for a valid medical reason and only after careful consideration of sonographic findings or family history of an abnormality for which screening with MRI might be beneficial. Before 18 weeks gestational age, a fetal MRI may not provide additional diagnostic information due to the small size of the fetus and fetal movement when compared with sonography. The need for early diagnosis should be balanced against the advantages of improved resolution later in pregnancy, with the choice dependent on the anomalies to be assessed.
 

Contraindications and Preferred Studies

  • Contraindications and reasons why a CT/CTA cannot be performed may include: impaired renal function, significant allergy to IV contrast, pregnancy (depending on trimester)
  • Contraindications and reasons why an MRI/MRA cannot be performed may include: impaired renal function, claustrophobia, non-MRI compatible devices (such as non- compatible defibrillator or pacemaker), metallic fragments in a high-risk location, patient exceeds weight limit/dimensions of MRI machine.

References

  1. Prayer D, Malinger G, De Catte L, De Keersmaecker B, Gonçalves L et al. ISUOG Practice Guidelines (updated): performance of fetal magnetic resonance imaging. Ultrasound in obstetrics gynecology: the official journal of the International. 2023; 61: 278-287. 10.1002/uog.26129.
  2. Kilcoyne A, Shenoy-Bhangle A, Roberts D, Sisodia R, Gervais D. MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. American Journal of Roentgenology. 2016; 208: 214 - 221. 10.2214/AJR.16.16281.

Coding Section 

Code Number Description
CPT 74712 MRI fetal, including placental and maternal pelvic imaging when performed, single or first gestation.
  74713 MRI fetal, including placental and maternal pelvic imaging when performed, each additional gestation (List separately in addition to code for primary procedure).

Procedure and diagnosis codes on Medical Policy documents are included only as a general reference tool for each policy. They may not be all-inclusive. 

This medical policy was developed through consideration of peer-reviewed medical literature generally recognized by the relevant medical community, U.S. FDA approval status, nationally accepted standards of medical practice and accepted standards of medical practice in this community, and other nonaffiliated technology evaluation centers, reference to federal regulations, other plan medical policies, and accredited national guidelines.

"Current Procedural Terminology © American Medical Association. All Rights Reserved" 

History From 2019 Forward     

11/01/2024

Annual review, no change to policy intent. Updating policy verbiage for clarity and consistency, including a section related to combination studies. Adding purpose statement, contraindication/preferred and purpose statement. Updating references.

11/09/2023

Annual review, no change to policy intent. Entire policy updated for clarity.
11/21/2022 Annual review, updating description. No change to policy intent

11/01/2021 

Annual review, no change to policy intent. Updating background and references. 

11/02/2020 

Annual review, no change to policy intent. 

11/19/2019

New Policy

Complementary Content
${loading}